31 – 40 of 2082
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Promising therapeutic targets for the treatment of urine storage dysfunction : what’s the status?
- Contribution to journal › Scientific review
-
Mark
Sex differences in expression of CGRP family of receptors and ligands in the rat trigeminal system
- Contribution to journal › Article
-
Mark
Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver
- Contribution to journal › Article
-
Mark
Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH
- Contribution to journal › Article
-
Mark
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis
- Contribution to journal › Article
-
Mark
Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking
- Contribution to journal › Article
-
Mark
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders
- Contribution to journal › Scientific review
-
Mark
Inhibition of aquaporin-9 ameliorates severe acute pancreatitis and associated lung injury by NLRP3 and Nrf2/HO-1 pathways
- Contribution to journal › Article
-
Mark
Effects of Coumarins from Roots of Paramignya scandens (Griff.) Craib on LPS-induced IL-1β and IL-10 Cytokine Production in RAW 264.7 Macrophages
- Contribution to journal › Article
-
Mark
Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteers
- Contribution to journal › Article
